Statement Of Cash Flows [Abstract]

Captor Therapeutics S.A. - Filing #6064395

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income (cost)
311,000 PLN
2 632 PLN
Adjustments to reconcile profit (loss) other than changes in working capital
28 297 PLN
19,000 PLN
Adjustments for decrease (increase) in trade and other receivables
25 881 PLN
3 073 PLN
Adjustments for increase (decrease) in trade and other payables
2 116 PLN
274,000 PLN
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets
424,000 PLN
3 005 PLN
Inflows of cash from investing activities
6 625 PLN
73 387 PLN
Outflows of cash from investing activities
6 352 PLN
53 456 PLN
Cash flows from (used in) financing activities [abstract]
Payments for share issue costs
105,000 PLN
1 108 PLN

Talk to a Data Expert

Have a question? We'll get back to you promptly.